<DOC>
	<DOCNO>NCT00781599</DOCNO>
	<brief_summary>Little known support need improve compliance Chantix smoking cessation . This two arm pilot study African American smoker provide vary level side effect management compliance support 12 week treatment period . The primary aim study estimate effect induction support compare standard care increase compliance Chantix month 3</brief_summary>
	<brief_title>Improving Medication Compliance Smoking Cessation Treatment Outcomes African American Smokers</brief_title>
	<detailed_description />
	<mesh_term>Varenicline</mesh_term>
	<criteria>African American 1875 year age Smoke 10 cigarette per day Have function telephone number Be interested quit smoke Be willing take 3 month Chantix Be willing complete study visit Renal impairment Evidence history clinically significant allergic reaction Chantix Cardiovascular event past month History alcohol drug abuse/dependency past year Major depressive disorder last year require treatment History panic disorder Psychosis , bipolar eat disorder Use antidepressant , antipsychotic , mood stabilizers/anticonvulsants naltrexone Use tobacco product cigarettes Use nicotine replacement therapy , bupropion , clonidine nortriptyline month prior enrollment Prior use Chantix Women pregnant , contemplate get pregnant breastfeeding Plans move Kansas City 3 month treatment phase Another household member enrol study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>June 2012</verification_date>
	<keyword>African american</keyword>
	<keyword>smoker</keyword>
	<keyword>smoke cessation</keyword>
	<keyword>African American smoker</keyword>
</DOC>